ATCC launched its second headquarters expansion with a groundbreaking ceremony that celebrates its continued commitment to innovative science and to the global scientific enterprise and to its local community in Prince William County.
ATCC announced the first launch from a portfolio of exosomes (i.e., extracellular vesicles) derived from human cells to serve as reference materials or standards for a variety of research applications.
ATCC announces the launch of a new authentication service that will allow researchers to easily confirm the identity of mouse cell lines.
ATCC launches its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret and reproduce their results with confidence.
ATCC presented data on ATCC’s efforts to provide scientists with fully authenticated and sequenced reference standards for microbiology research. ATCC believes these standards will enhance the quality, integrity, and reproducibility of research.
ATCC, in partnership with the Institute for Life Science Entrepreneurship (ILSE), announces the expansion of its Global Priority Superbugs portfolio, which is a comprehensive collection of authenticated priority pathogens used to aid research and development efforts for novel therapies and advanced detection methods for antimicrobial resistance (AMR).
At the American Association for Cancer Research (AACR) Annual Meeting 2019 ATCC presented multiple posters that showcase ATCC’s innovative technologies and next-generation precision models that are at the forefront of cancer research.
ATCC's partnership with the procurement platform Science Exchange will promote reproducibility, support drug discovery and development, and streamline and personalize the procurement process.